Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without Sonrotoclax for Patients With Richter Transformation
Clinical trial NCT04271956 · RECRUITING
Trial details
- NCT number
- NCT04271956
- Sponsor
- German CLL Study Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2027-08-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.